Literature DB >> 18203285

Influence of kavain on hepatic ultrastructure.

Shuang Fu1, Emine Korkmaz, Filip Braet, Quan Ngo, Iqbal Ramzan.   

Abstract

AIM: To investigate whether the major kavalactone kavain imposes adverse effects on the liver ultrastructure and function by affecting vascular and microvascular architecture and altering hepatocellular morphology.
METHODS: Kavain solution (10 microg/mL or 43.5 micromol/L) was perfused for 2 h in isolated rat livers. After standard fixation and tissue preparation, the samples were examined by scanning electron microscopy (SEM), transmission electron microscopy (TEM), and light microscopy (LM).
RESULTS: LM, SEM, and TEM examinations indicated kavain-treated rat livers (n=4) displayed severe vascular and endothelial damage compared to control livers (n=4).
CONCLUSION: The data so far support the hypothesis that kavain induces adverse effects on liver; additional investigations with other kavalactones and their effects on liver are urgently needed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18203285      PMCID: PMC2681144          DOI: 10.3748/wjg.14.541

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  23 in total

Review 1.  Physiological role of sinusoidal endothelial cells and Kupffer cells and their implication in the pathogenesis of liver injury.

Authors:  S Arii; M Imamura
Journal:  J Hepatobiliary Pancreat Surg       Date:  2000

2.  Chemistry of kava.

Authors:  M W Klohs
Journal:  Psychopharmacol Bull       Date:  1967-12

Review 3.  Therapeutic potential of kava in the treatment of anxiety disorders.

Authors:  Yadhu N Singh; Nirbhay N Singh
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

4.  [Fulminant liver failure after administration of the herbal antidepressant Kava-Kava].

Authors:  M Kraft; T W Spahn; J Menzel; N Senninger; K H Dietl; H Herbst; W Domschke; M M Lerch
Journal:  Dtsch Med Wochenschr       Date:  2001-09-07       Impact factor: 0.628

5.  Kava and valerian in the treatment of stress-induced insomnia.

Authors:  D Wheatley
Journal:  Phytother Res       Date:  2001-09       Impact factor: 5.878

Review 6.  Herbal medicines in Hawaii from tradition to convention.

Authors:  S A Norton
Journal:  Hawaii Med J       Date:  1998-01

7.  Disposition of amphotericin B in the isolated perfused rat liver.

Authors:  Ying Hong; Iqbal Ramzan; Andrew J McLachlan
Journal:  J Pharm Pharmacol       Date:  2004-01       Impact factor: 3.765

Review 8.  Kava extract for treating anxiety.

Authors:  M H Pittler; E Ernst
Journal:  Cochrane Database Syst Rev       Date:  2002

Review 9.  Kava: an overview.

Authors:  Y N Singh
Journal:  J Ethnopharmacol       Date:  1992-08       Impact factor: 4.360

Review 10.  Toxicity of kava pyrones, drug safety and precautions--a case study.

Authors:  Johannes Schulze; Walter Raasch; Claus-Peter Siegers
Journal:  Phytomedicine       Date:  2003       Impact factor: 5.340

View more
  3 in total

1.  Assessment and histological analysis of the IPRL technique for sequential in situ liver biopsy.

Authors:  Anthony Rowe; Lillian Zhang; Azmena Hussain; Filip Braet; Iqbal Ramzan
Journal:  Comp Hepatol       Date:  2011-08-08

2.  Liver toxicity and carcinogenicity in F344/N rats and B6C3F1 mice exposed to Kava Kava.

Authors:  Mamta Behl; Abraham Nyska; Rajendra S Chhabra; Gregory S Travlos; Laurene M Fomby; Barney R Sparrow; Milton R Hejtmancik; Po C Chan
Journal:  Food Chem Toxicol       Date:  2011-08-18       Impact factor: 6.023

3.  Toxicokinetics of kava.

Authors:  Anthony Rowe; Lillian Yuan Zhang; Iqbal Ramzan
Journal:  Adv Pharmacol Sci       Date:  2011-03-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.